ArticleDiabetologia2013
The use of intermediate endpoints in the design of type 1 diabetes prevention trials.
Jeffrey P Krischer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this papertrialcites it
ArticleDiabetologia2013
Jeffrey P Krischer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.